CLASS II Device recall · Reported 9 May 2018 · FDA Enforcement Report

Atellica Solution and Atellica Sample Handler Prime recalled

Siemens Healthcare Diagnostics is recalling Atellica Solution and Atellica Sample Handler Prime for in vitro diagnostic testing of, distributed in Florida. The recall was initiated on 26 Feb 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI 00630414002439
Quantity recalledN/A

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1587-2018
FDA event ID
79683
Recalling firm
Siemens Healthcare Diagnostics, Tarrytown, NY
Classification
Class II
Status
Terminated
Recall initiated
26 Feb 2018
FDA classified
1 May 2018
Reported
9 May 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

26 Feb 2018Recall initiated by company
1 May 2018Classified by FDA+64 days
9 May 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

When more than one immunoassay analyzer is connected to a single solution system, reporting and conversion factors may not be applied to all analyzers

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Atellica Solution and Atellica Sample Handler Prime for in vitro diagnostic testing of clinical specimens.

Where it was distributed

FL and France Spain Sweden United Kingdom Germany

Florida

Questions about this recall

Is Atellica Solution and Atellica Sample Handler Prime for in vitro diagnostic testing of recalled?

Yes. Siemens Healthcare Diagnostics recalled Atellica Solution and Atellica Sample Handler Prime for in vitro diagnostic testing of on 26 Feb 2018. The recall is Class II and its status is Terminated. Recall number Z-1587-2018.

Why was it recalled?

When more than one immunoassay analyzer is connected to a single solution system, reporting and conversion factors may not be applied to all analyzers

Which lots are affected?

UDI 00630414002439

Where was it sold?

FL and France Spain Sweden United Kingdom Germany

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Test Kits & Diagnostics recalls

All 2,656